Cargando…

Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway

BACKGROUND: Epirubicin is a first-line chemotherapeutic drug for the clinical treatment of diffuse large B cell lymphoma (DLBCL), but the overexpression of multidrug resistance (MDR) transporter proteins, especially P-glycoprotein (P-gp), renders epirubicin ineffective. Some studies reveal the poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kaili, Song, Jincheng, Yan, Yue, Zou, Kun, Che, Yuxuan, Wang, Beichen, Li, Zongjuan, Yu, Wendan, Guo, Wei, Zou, Lijuan, Deng, Wuguo, Sun, Xiuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527585/ https://www.ncbi.nlm.nih.gov/pubmed/33007707 http://dx.doi.org/10.1016/j.tranon.2020.100876

Ejemplares similares

β-Elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial–mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway
por: Zou, Kun, et al.
Publicado: (2020)

Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM/NF-κB signaling
por: Che, Yilin, et al.
Publicado: (2018)

β-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-κB/HIF-1α signaling pathway
por: Yu, Xiaomu, et al.
Publicado: (2019)

Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways
por: Yi, Canhui, et al.
Publicado: (2014)

Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
por: Li, Zongjuan, et al.
Publicado: (2020)

Melatonin protects against Epirubicin-induced ovarian damage
por: WANG, Naiqiang, et al.
Publicado: (2019)

Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro
por: Lu, Jian, et al.
Publicado: (2021)

Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel
por: Wang, Cheng, et al.
Publicado: (2015)

Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB
por: Shirai, Yoshihiro, et al.
Publicado: (2018)

Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-κB Activity and Regulating Bax/Bcl-2 Expression
por: Zhang, Shuaishuai, et al.
Publicado: (2016)

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
por: Jiang, Wei, et al.
Publicado: (2020)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
por: Porciani, David, et al.
Publicado: (2015)

High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
por: Lin, Yang, et al.
Publicado: (2015)

Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB
por: He, Jianming, et al.
Publicado: (2017)

Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT/NF-κB pathway
por: Sun, Jianguo, et al.
Publicado: (2019)

Inactivation of AKT/NF-κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin
por: Dukaew, Nahathai, et al.
Publicado: (2020)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
por: Zhao, Na, et al.
Publicado: (2014)

Chemosensitization in non-small cell lung cancer cells by IKK inhibitor occurs via NF-κB and mitochondrial cytochrome c cascade
por: Jin, Xianqing, et al.
Publicado: (2009)

Secondary hemophagocytic lymphohistiocytosis triggered by peripheral T‐cell lymphoma: An unusual case report
por: Che, Yuxuan, et al.
Publicado: (2022)

Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
por: Liu, Jiangbo, et al.
Publicado: (2014)

Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
por: Lallo, Subehan, et al.
Publicado: (2022)

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma
por: Xu, Cong, et al.
Publicado: (2022)

Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells
por: Lu, Jian-Jun, et al.
Publicado: (2015)

Recent advances in CAR T-cell therapy for lymphoma in China
por: Che, Yuxuan, et al.
Publicado: (2023)

Anthocyanidins Inhibit Growth and Chemosensitize Triple-Negative Breast Cancer via the NF-κB Signaling Pathway
por: Aqil, Farrukh, et al.
Publicado: (2021)

Effusanin E Suppresses Nasopharyngeal Carcinoma Cell Growth by Inhibiting NF-κB and COX-2 Signaling
por: Zhuang, Mingzhu, et al.
Publicado: (2014)

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
por: Hao, Jiaojiao, et al.
Publicado: (2019)

Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis
por: Chen, Jun-Feng, et al.
Publicado: (2017)

Inhibition LC3B can increase chemosensitivity of ovarian cancer cells
por: Tang, Jing, et al.
Publicado: (2019)

Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
por: Shi, Yuanfei, et al.
Publicado: (2022)

Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols
por: Suttana, Wipob, et al.
Publicado: (2010)

PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
por: Yu, Wendan, et al.
Publicado: (2020)

Melatonin Inhibits Annulus Fibrosus Cell Senescence through Regulating the ROS/NF-κB Pathway in an Inflammatory Environment
por: Li, Jing, et al.
Publicado: (2021)

Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65
por: Cai, Mingsheng, et al.
Publicado: (2023)

Immune-Pineal Axis: Nuclear Factor κB (NF-κB) Mediates the Shift in the Melatonin Source from Pinealocytes to Immune Competent Cells
por: Markus, Regina P, et al.
Publicado: (2013)

Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
por: Yu, Zhenlong, et al.
Publicado: (2014)

MicroRNA-34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel
por: Yanokura, Megumi, et al.
Publicado: (2020)

Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors
por: Li, Shuping, et al.
Publicado: (2020)

Melatonin Reduces Inflammatory Injury Through Inhibiting NF-κB Activation in Rats With Colitis
por: Li, Jun-Hua, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_pvamfran7aodvmnkppl5dmgup7